MS#CLIFERC2711B

China Life Insurance Releases ESG Report with Total Premiums Exceeding 700 Billion

CMBI Maintains Buy Rating on China Life with Target Price Hike

China CITIC and China Merchants Securities Maintain Buy Rating for China Life

Hanzhong's Long-Term Care Insurance System Aligns with New Rules, Enhancing Efficiency with 'Digital and Intelligent' Services Involving China Life

Listed insurance firms' Q1 net profit generally fell by nearly 17%, with the market anticipating a subsequent recovery

CMBI Raises Life Insurance Target Price to 34 HKD, Maintains Buy Rating

Goldman Sachs Raises 2026 Profit Forecast for China Life by 8%

Morgan Stanley Raises Target Price for China Life to HKD 38.9

China Ping An Life Insurance Increases Holdings in China Life

UBS Report: China Life Sees 76% Increase in New Business Value, 32% Drop in Net Profit in Q1

The total net profit of the five major listed insurance companies decreased by 16.98% in Q1 2026, but the new business value of life insurance saw comprehensive growth

China Ping An Insurance Buys 1.266 Million Shares of China Life Insurance

JPMorgan Releases Q1 Earnings Analysis for China Life

Fujian Xinrui Relay Sci-Tech Equity Investment Partnership Established with an Investment of About 4 Billion Yuan

CHINA LIFE released FY2026 Q1 earnings on April 29 After-Market (BJT), actual revenue HKD 61.86 B, actual EPS HKD 0.7822

LaSalle Investment Management and National Life Capital Collaborate on Shanghai Long-Term Rental Apartment Acquisition

China Life Releases 2025 ESG Report, MSCI Rating Upgraded to AA

China Life Insurance Reports 75.5% Increase in New Business Value in Q1

China Life Sees Growth in Sales Force Quality in Q1

China Life's Q1 2026 Net Profit Falls 32.3% to 19.505 Billion Yuan

RONGZUN INT’L H

ASIA PIONEER

160 HEALTH

VC HOLDINGS

CENTRALCHINA MT

ASTRUM

HENGDELI

HAITIAN ANTENNA

CN CULTURE GP

TOMO HOLDINGS

601628

02628

China Life's 2025 ESG report reveals total premiums exceeding 7,000 billion yuan and an MSCI ESG rating upgrade to AA. The company ranks No. 1 on S&P Global’s Global Top 50 insurers list. Key highlights include 1.82 trillion yuan in green insurance risk protection, operational decarbonization targets of 10% emissions reduction by 2030, and a paperless policy enrollment rate of 99.9%. Consumer outcomes show claims processing time reduced to 0.36 days and a commercial insurance payout rate of 99.6%.

PUBT

China Life

CHINA LIFE

S&P Global

MSCI

China Life ESG report shows 2025 premiums top 7,000 billion yuan, MSCI rating AA

Citic Securities has maintained a Buy rating on China Life Insurance Co (CILJF) as of May 6, with a price target of HK$36.00, while the shares closed at HK$29.90. The overall analyst consensus for the company is a Strong Buy, with an average price target of HK$35.57, indicating an 18.96% upside. Additionally, CMB International Securities also supports a Buy rating with a target of HK$34.00.

Tip Ranks

CITIC SEC

CITIC Securities Co., Ltd.

China Life Insurance Co (CILJF) Receives a Buy from Citic Securities

02378

601601

02601

02328

01299

Yesterday, Prudential's stock price surged by 4.04% at the close, with a trading volume of approximately HKD 42.95 million. The price and volume were well-coordinated, clearly breaking through the recent consolidation range. The MACD daily bullish signal has been established with strong momentum, and the short-term momentum indicators are accelerating divergence, which usually indicates that buying power is forming a consistent directional expectation, confirming a phase of upward trend. In terms of market performance, the stock price maintained strength throughout the day, closing in the high range of the day, with clear signals of bullish control. On the news front, the insurance sector collectively strengthened yesterday, with China Life rising by 4.28%, PICC P&C by 5.91%, CPIC by 3.37%, and AIA by 1.94%, forming a strong collective breakout trend in the sector. Prudential, as an international insurance giant covering the Asian and African markets, benefits from the long-term logic of increasing insurance penetration in emerging Asian markets. Recently, although Federal Reserve officials warned of inflation risks and the possibility of interest rate hikes, the high interest rates provide positive support for the investment income of insurance companies. The improvement in market risk appetite driven by the ceasefire sentiment also favors the valuation recovery of insurance stocks. Technically, the stock price has broken through the 5-day and 10-day moving average resistance, and the short-term moving average system is beginning to shift to a bullish arrangement. The trading volume has significantly increased compared to previous days, making the breakout action effective. The overall strength of the insurance sector provides strong support for individual stocks, and today it is necessary to pay attention to whether the sector's heat can continue. The short-term trend is biased towards bullish, with sector resonance combined with individual stock technical breakthroughs, indicating a high signal strength

Technical Forecast

CPIC

PICC P&C

Prudential plc

Prudential

Prudential USD

AIA-R

AIA Group

Pre-market trend | Prudential (2378.HK) surged over 4% on May 7 with increased volume, are the main players in the insurance sector buying up?

PNGAY

601318

02318

BofAS reported that Chinese insurers' 1QYY results were solid despite stock market volatility affecting investment income. CHINA LIFE saw a 32% YoY decline in net profit, while NCI posted an unexpected 11% profit increase. PING AN and CPIC delivered stable results. BofAS believes the market has absorbed weak profit factors and investors will focus on long-term growth. Their top picks are PING AN and CHINA LIFE, with target prices of HKD74 and HKD33.1, respectively, both rated as Buy.

AASTOCKS News

Ping An Insurance

Ping An

PING AN

PING AN-R

BofAS: 1QYY Results of Chinese Insurers Solid; Top Picks PING AN , CHINA LIFE

CMBI has raised the target price for CHINA LIFEfrom HKD33 to HKD34 following a mixed performance in 1Q26. The company's net profit fell 32.3% YoY to RMB19.5 billion, missing forecasts due to stock market volatility. However, new business value surged 75.5% YoY, indicating strong growth potential. The broker maintains a Buy rating, optimistic about earnings growth in Q2, supported by a stock market rebound and effective asset-liability management.

CMBI Raises CHINA LIFE  TP to HKD34; Strong 1Q26 NBV

08296

Morgan Stanley has raised its target price for CHINA LIFEfrom HKD37.9 to HKD38.9, reflecting a 2.6% increase. This adjustment follows strong growth in the company's new business value in Q1 2026, prompting slight increases in earnings forecasts for 2026 to 2028 by 0.1%, 0.3%, and 0.4%. The firm maintains an Overweight rating on the stock.

SINO-LIFE GROUP

Morgan Stanley

MORGAN STANLEY DEP SHS EA REP 1/1000 SHS NON CUM PFD O

MORGAN STANLEY DEP SHS REPSTG 1/1000TH PFD SER Q

MORGAN STANLEY DEP SHS REPS 1/1000 7.125% PFD E

MORGAN STANLEY NON-CUM DEP SH REP 1/1000 PFD SER I

MORGAN STANLEY 4.875 DEP SHS REP 1/1000 NCUM PFD SR L

MORGAN STANLEY 6.5%DEP SHS REPSTG 1/1000 NON CUM SER P

MORGAN STANLEY DEP SHS REPS 1/1000 PFD SER 'A'

MORGAN STANLEY DEP SHS REPR 1/1000TH INT PFD SER 'F' FX

MORGAN STANLEY DEP SHS REP 1/1000 NON-CUM PFD STK SER K

M Stanley Raises CHINA LIFE  TP to HKD38.9, Reiterates Overweight

CICC reported that CHINA LIFEexceeded expectations in its 1Q26 results, with a 75.5% YoY increase in new business value (NBV), despite a 32.3% YoY decline in net profit to RMB19.505 billion. CICC maintained its Outperform rating and unchanged earnings forecasts, setting a target price of RMB60.3 for A shares and HKD44.5 for H shares, indicating potential upside of 65% and 62%, respectively.

CICC

CICC: CHINA LIFE  1Q26 NBV Far Exceeds Expectations; Maintains Outperform Rating

UBS reported that CHINA LIFEachieved a 76% year-on-year increase in new business value for 1Q26, significantly surpassing expectations. However, the company's net profit after tax fell 32% year-on-year to RMB20 billion, aligning with market forecasts due to weak equity performance and high investment leverage. UBS maintains a Buy rating on CHINA LIFE with a target price of HKD40.

UBS Group AG

UBS: CHINA LIFE  1Q26 New Business Value +76% YoY Far Beats; Buy, TP HKD40

Hong Kong stocks declined ahead of the May 1 holiday, with the HSI closing down 335 points at 25,776. China Life rose 4.5% after quarterly results, while SMIC gained 7.8%. Brent oil futures reached $120.92 per barrel. The US Federal Reserve maintained interest rates, and the DJIA fell 0.6%. Southbound trading will be suspended during the holiday. YOFC shares plummeted 13.8% after disappointing Q1 results, despite significant year-on-year profit growth. Overall, the HSI saw a weekly decline of 0.8%, but a monthly gain of 4%.

Dow Jones Industrial Average

NASDAQ Composite Index

SSE Index

Shenzhen Index

Hang Seng Index

Hang Seng China Enterprises Index

Hang Seng TECH Index

BYD COMPANY

XIAOMI-W

Xiaomi Corporation

Cambricon

SMIC

HUA HONG SEMI

Hua Hong

ILUVATAR COREX

BIREN TECH

KNOWLEDGE ATLAS

TENCENT

Tencent

NTES-S

NetEase

BABA-W

Alibaba

KUAISHOU-W

JD-SW

JD.com

BIDU-SW

Baidu

MEITUAN

Meituan

YOFC

BYD HK SDR 10to1

BYD Company

BYD Company Limited

BYD COMPANY-R

XIAOMI-WR

Xiaomi HK SDR 2to1

SMIC HK SDR 5to1

TENCENT-R

Tencent HK SDR 10to1

Tencent Holdings Limited

BABA-WR

Alibaba HK SDR 5to1

KUAISHOU-WR

JD-SWR

BIDU-SWR

MEITUAN-WR

Meituan HK SDR 5to1

Hong Kong Stocks Weaken Ahead of Long Holiday; CHINA LIFE  Up 4%; SMIC Sought After

NCIshares rose 2.8% at midday, closing at HKD52. BofAS reported a net profit of RMB6.5 billion for 1Q26, up 11% YoY, but noted one-off gains. NCI's investment yield was 2.1%, lower than CHINA LIFE's 2.2%. M Stanley and UBS also reported positive earnings, with M Stanley assigning an Underweight rating and a TP of HKD43, while UBS maintained a Neutral rating with a TP of HKD48.5. Overall, NCI's performance exceeded market expectations despite challenges in the equity market.

MS#CLIFERC2711B(55199.HK)

China Life ESG report shows 2025 premiums top 7,000 billion yuan, MSCI rating AA

China Life Insurance Co (CILJF) Receives a Buy from Citic Securities

Pre-market trend | Prudential (2378.HK) surged over 4% on May 7 with increased volume, are the main players in the insurance sector buying up?

BofAS: 1QYY Results of Chinese Insurers Solid; Top Picks PING AN , CHINA LIFE

CMBI Raises CHINA LIFE TP to HKD34; Strong 1Q26 NBV

M Stanley Raises CHINA LIFE TP to HKD38.9, Reiterates Overweight

CICC: CHINA LIFE 1Q26 NBV Far Exceeds Expectations; Maintains Outperform Rating

UBS: CHINA LIFE 1Q26 New Business Value +76% YoY Far Beats; Buy, TP HKD40

Hong Kong Stocks Weaken Ahead of Long Holiday; CHINA LIFE Up 4%; SMIC Sought After

NCI Up 2.8% at Midday; Brokers Say 1Q26 Earnings Beat Expectations